Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors

Atherosclerosis is an underlying risk factor in cardiovascular diseases (CVDs). The combination of drugs with microRNAs (miRNA) inside a single nanocarrier has emerged as a promising anti-atherosclerosis strategy to achieve the exploitation of their complementary mechanisms of action to achieve syne...

Descripción completa

Detalles Bibliográficos
Autores principales: Leal, Baltazar Hiram, Velasco, Brenda, Cambón, Adriana, Pardo, Alberto, Fernandez-Vega, Javier, Arellano, Lilia, Al-Modlej, Abeer, Mosquera, Víctor X., Bouzas, Alberto, Prieto, Gerardo, Barbosa, Silvia, Taboada, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879452/
https://www.ncbi.nlm.nih.gov/pubmed/35213991
http://dx.doi.org/10.3390/pharmaceutics14020258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879452/
https://www.ncbi.nlm.nih.gov/pubmed/35213991
http://dx.doi.org/10.3390/pharmaceutics14020258

Ejemplares similares